Completed PHASE1 INTERVENTIONAL 2-arm NCT01354041

Fear of Recurrence Pilot Intervention for Women With Breast Cancer (WiLLoW)

A Pilot Intervention to Address Fear of Recurrence in Breast Cancer Survivors

Sponsor: University of California, San Francisco

Interventions Acceptance and Commitment Therapy

Updated 5 times since 2017 Last updated: Jan 23, 2014 Started: Mar 31, 2011 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Cancer Recurrence and is currently completed. University of California, San Francisco leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of California, San Francisco

Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States